Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Nailfold Capillary Changes in People With Psoriasis

Studies nail-fold blood vessel changes by microscope in people with psoriasis.

Plain-language title generated from the registry record
Registry title: Nailfold Capillaroscopic Changes in Psoriasis

Key facts

Where
Cairo, EgyptSee the site

Where in Egypt

  • Al-Hussein University Hospital & Sayed Galal University HospitalCairo, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Al-Azhar University
Trial code
NCT07693595
Record updated
31 July 2026
Original description
The goal of this observational study is to evaluate nailfold capillaroscopic changes in patients with psoriasis and to assess their correlation with disease severity. The study will also explore differences in capillaroscopic findings across different clinical types of psoriasis and skin phototypes (Fitzpatrick classification). The study will include patients diagnosed with psoriasis attending dermatology outpatient clinics. Participants will undergo clinical assessment and nailfold capillaroscopy to detect microvascular changes.Read full original descriptionShow less

Nailfold Capillaroscopic Changes in Psoriasis and Its Correlation With Disease Severity

The goal of this observational study is to evaluate nailfold capillaroscopic changes in patients with psoriasis and to assess their correlation with disease severity. The study will also explore differences in capillaroscopic findings across different clinical types of psoriasis and skin phototypes (Fitzpatrick classification). The study will include patients diagnosed with psoriasis attending dermatology outpatient clinics. Participants will undergo clinical assessment and nailfold capillaroscopy to detect microvascular changes.

Inclusion: Patients clinically diagnosed with psoriasis.

Exclusion: Patients with connective tissue diseases (e.g., systemic sclerosis, SLE); Diabetes mellitus or peripheral vascular disease; Current smokers; Pregnant or lactating women; Recent use of vasodilators or beta-blockers; Manual workers exposed to vibrating tools.

ClinicalTrials.gov NCT07693595